Amplifye
PrivateLast Round
Series A
Jul 15, 2024
Total Funding Raised
$18.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Amplifye operates in Healthcare & Life Sciences and is based in Davis, California. Its latest recorded funding round was a Series A round in July 2024.
Amplifye is a biotechnology company that develops proprietary protease enzymes using artificial intelligence and computational protein design to enhance protein digestion and nutrient absorption.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplifye Comparables
Compare Amplifye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiOptimizers | 78% | |
| Innophos | 72% | |
| International Flavors & Fragrances Inc. | 62% |
For institutional investors. Book with your work email.
Amplifye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 15, 2024 | ||||
| Seed | May 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amplifye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The March Fund | Seed, Series A |
| Astanor Ventures | Seed, Series A |
| UC Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 49% MoM.
- Jul 28, 2026
Monthly visitors increased 37% MoM.
For institutional investors. Book with your work email.
Amplifye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amplifye's valuation, stock price, and market status.
Is Amplifye a public or private company?
Amplifye is a private company.
What is the current stock price of Amplifye?
Amplifye is a private company, so its shares have no public market price. Caplight tracks Amplifye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amplifye worth (valuation)?
Valuation information for Amplifye is not publicly available.
Can I buy Amplifye stock?
Amplifye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amplifye's last funding round?
Amplifye's most recent funding round was Series A on July 15, 2024.
Who are the main investors in Amplifye?
Key investors in Amplifye include The March Fund, Astanor Ventures, UC Investments.
Will Amplifye IPO soon?
No public IPO plans have been announced for Amplifye.
How can I track Amplifye secondary market activity?
Caplight tracks bids, offers, and trades in Amplifye's shares on secondary markets.